Order Article Reprints

Guarrochena X, Kanellopoulos P, Stingeder A, Rečnik L-M, Feiner IVJ, Brandt M, Kandioller W, Maina T, Nock BA, Mindt TL. Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability. Pharmaceutics. 2024; 16(3):392. https://doi.org/10.3390/pharmaceutics16030392

Guarrochena, Xabier, Panagiotis Kanellopoulos, Anna Stingeder, Lisa-Maria Rečnik, Irene V. J. Feiner, Marie Brandt, Wolfgang Kandioller, Theodosia Maina, Berthold A. Nock, and Thomas L. Mindt. 2024. "Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability" Pharmaceutics 16, no. 3: 392. https://doi.org/10.3390/pharmaceutics16030392

Guarrochena, X., Kanellopoulos, P., Stingeder, A., Rečnik, L.-M., Feiner, I. V. J., Brandt, M., Kandioller, W., Maina, T., Nock, B. A., & Mindt, T. L. (2024). Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability. Pharmaceutics, 16(3), 392. https://doi.org/10.3390/pharmaceutics16030392